|
|
|
Volumn 11, Issue 4, 2010, Pages 324-327
|
|
Novel agents for the treatment of pancreatic adenocarcinoma: Any light at the end of the tunnel?
a
|
|
Author keywords
Cytotoxic T lymphocyte antigen 4; IGF type 1; Ixabepilone; Pancreatic neoplasms; Receptor; Receptors, somatomedin; Taxoids
|
|
Indexed keywords
AMG 479;
ANTINEOPLASTIC AGENT;
CETUXIMAB;
CONATUMUMAB;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;
EPIDERMAL GROWTH FACTOR RECEPTOR;
EPOTHILONE DERIVATIVE;
ERLOTINIB;
GEMCITABINE;
INSULIN GROWTH FACTOR RECEPTOR 1;
IXABEPILONE;
MK 0646;
PACLITAXEL;
SOMATOMEDIN RECEPTOR;
TAXANE DERIVATIVE;
TICILIMUMAB;
UNCLASSIFIED DRUG;
VANDETANIB;
ACNE;
ADVANCED CANCER;
ANEMIA;
ARTICLE;
CANCER SURVIVAL;
CANCER THERAPY;
CLINICAL TRIAL;
DIARRHEA;
DOSAGE SCHEDULE COMPARISON;
DOSE RESPONSE;
DRUG DOSE COMPARISON;
DRUG DOSE ESCALATION;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
DRUG SAFETY;
DRUG TARGETING;
DRUG TOLERABILITY;
FATIGUE;
FEBRILE NEUTROPENIA;
HUMAN;
HYPERGLYCEMIA;
HYPERTENSION;
HYPOMAGNESEMIA;
LEUKOPENIA;
LIVER FUNCTION TEST;
METASTASIS;
MONOTHERAPY;
MUCOSA INFLAMMATION;
MULTIPLE CYCLE TREATMENT;
NAUSEA;
NEUTROPENIA;
OVERALL SURVIVAL;
PANCREAS ADENOCARCINOMA;
PANCREAS CANCER;
PERIPHERAL NEUROPATHY;
RASH;
SIDE EFFECT;
THROMBOCYTOPENIA;
TREATMENT DURATION;
TREATMENT PLANNING;
VOMITING;
ADENOCARCINOMA;
EVALUATION STUDY;
ISOLATION AND PURIFICATION;
MEDICAL SOCIETY;
ONCOLOGY;
ORGANIZATION;
ORGANIZATION AND MANAGEMENT;
PANCREATIC NEOPLASMS;
PROCEDURES;
TRENDS;
UNITED STATES;
ADENOCARCINOMA;
ANTINEOPLASTIC AGENTS;
CHICAGO;
CONGRESSES AS TOPIC;
HUMANS;
MEDICAL ONCOLOGY;
PANCREATIC NEOPLASMS;
SOCIETIES, MEDICAL;
UNITED STATES;
|
|
EID: 77954777571
PISSN: None
EISSN: 15908577
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (7)
|
|
References (10)
|
